# Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study

> **NCT00715286** · PHASE3 · UNKNOWN · sponsor: **All India Institute of Medical Sciences** · enrollment: 180 (estimated)

## Conditions studied

- Ovarian Carcinoma

## Interventions

- **OTHER:** timing of surgery
- **OTHER:** timing of surgery

## Key facts

- **NCT ID:** NCT00715286
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2001-11
- **Primary completion:** 2007-04
- **Final completion:** 2009-06
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2008-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715286, "Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00715286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*